Down-regulation of annexin A1 and A2 protein expression in intestinal-type sinonasal adenocarcinomas

Juan P Rodrigo1, Juana M García-Pedrero, José L Llorente

  • 1Department of Otolaryngology, Hospital Universitario Central de Asturias, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, Oviedo, Spain. juanpablo.rodrigo@sespa.princast.es

Human Pathology
|October 26, 2010
PubMed

Insights

Annexin A1 expression is frequently lost in intestinal-type sinonasal adenocarcinoma. Annexin A2 expression is reduced and linked to aggressive tumor types, impacting patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pathology

Background:

  • Annexins are calcium- and phospholipid-binding proteins involved in cellular processes.
  • Altered annexin expression is linked to tumor development and progression.

Purpose of the Study:

  • To investigate the expression of annexin A1 and annexin A2 in intestinal-type sinonasal adenocarcinoma.
  • To assess the role of annexin A1 and A2 in the pathogenesis of these tumors.

Main Methods:

  • Immunohistochemistry was used to study annexin A1 and A2 expression.
  • A tissue microarray of 57 intestinal-type sinonasal adenocarcinomas was analyzed.

Main Results:

  • Annexin A1 expression was lost in 91% of tumors compared to normal epithelium.
  • Annexin A2 expression was heterogeneous (33% negative) and lower in mucinous types (P = .022).
  • Loss of annexin A2 correlated with reduced survival (P = .004) but was not an independent predictor.

Conclusions:

  • Annexin A1 is frequently lost in intestinal-type sinonasal adenocarcinoma.
  • Reduced annexin A2 expression is associated with more aggressive histopathological types in these tumors.